Position in CELC
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$584,930
-$40,557 QoQ
Shares Held
5,591
+2.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#164
of 273 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GREAT VALLEY ADVISOR GROUP, INC. holds $5,771,539 across 13 Biotechnology names. CELC ranks #2 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,947 | $2,734,138 | |
| 2 | CELC |
Celcuity Inc.
This page
|
5,591 | $584,930 | |
| 3 | INCY |
Incyte Corp
|
5,040 | $571,334 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
874 | $434,142 | |
| 5 | SMMT |
Summit Therapeutics Inc.
|
25,840 | $376,488 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,080 | $260,247 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
379 | $236,321 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
2,700 | $201,096 |
All Filings in CELC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $584,930 | 5,591 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $625,487 | 5,480 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $521,640 | 5,230 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $257,621 | 5,215 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||